The trypanosoma rangeli trypomastigote surfaceome reveals novel proteins and targets for specific diagnosis

Journal of Proteomics

Volumn 82, Issue , 2013, Pages 52-63

  Wagner, Glauber ^a,b,c   Eiko Yamanaka, Lais ^a   Moura, Hércules ^c   Denardin Lückemeyer, Débora ^a   Schlindwein, Aline Daiane ^a   Hermes Stoco, Patricia ^a   Bunselmeyer Ferreira, Henrique ^d   Robert Barr, John ^c   Steindel, Mario ^a   Grisard, Edmundo Carlos ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSIDADE DO OESTE DE SANTA CATARINA   (Brazil)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antigens; GPI anchored proteins; Proteomic; Surface proteins; Trypanosoma rangeli

Indexed keywords

CALCIUM BINDING PROTEIN; MEMBRANE PROTEIN;

ARTICLE; DIAGNOSTIC ERROR; ELECTROSPRAY MASS SPECTROMETRY; IMMUNOBLOTTING; LIQUID CHROMATOGRAPHY; NONHUMAN; PARASITE; PRIORITY JOURNAL; PROTEOMICS; TANDEM MASS SPECTROMETRY; TRYPANOSOMA CRUZI; TRYPANOSOMA RANGELI; TRYPOMASTIGOTE;

ANIMALS; HUMANS; MICE; PROTEOMICS; PROTOZOAN PROTEINS; SEROLOGIC TESTS; TRYPANOSOMA RANGELI; TRYPANOSOMIASIS;

MAMMALIA; MUS; TRYPANOSOMA CRUZI; TRYPANOSOMA RANGELI; TRYPANOSOMATIDAE;

EID: 84875761938     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.02.011     Document Type: Article

References (74)

1. D'Alessandro A. Biology of Trypanosoma (Herpetosoma) rangeli Tejera. Biology of the Kinetoplastida 1976, 327-403. London Academic, London. W.H.R. Lumsden, D.A. Evans (Eds.).
2. Coura J.R., Fernandes O., Arboleda M., Barrett T.V., Carrara N., Degrave W., et al. Human infection by Trypanosoma rangeli in the Brazilian Amazon. Trans R Soc Trop Med Hyg 1996, 90:278-279.
3. Calzada J.E., Pineda V., Garisto J.D., Samudio F., Santamaria A.M., Saldana A. Human trypanosomiasis in the eastern region of the Panama Province: new endemic areas for Chagas disease. Am J Trop Med Hyg 2010, 82:580-582.
4. WHO Chagas disease (American trypanosomiasis) 2012, Fact Sheet No 340, World Health Organization.
5. Saldana A., Samudio F., Miranda A., Herrera L.M., Saavedra S.P., Caceres L., et al. Predominance of Trypanosoma rangeli infection in children from a Chagas disease endemic area in the west-shore of the Panama canal. Mem Inst Oswaldo Cruz 2005, 100:729-731.
6. de Sousa M.A., da Silva Fonseca T., Dos Santos B.N., Dos Santos Pereira S.M., Carvalhal C., Hasslocher Moreno A.M. Trypanosoma rangeli Tejera, 1920, in chronic Chagas' disease patients under ambulatory care at the Evandro Chagas Clinical Research Institute (IPEC-Fiocruz, Brazil). Parasitol Res 2008, 103:697-703.
7. Vallejo G.A., Guhl F., Carranza J.C., Lozano L.E., Sanchez J.L., Jaramillo J.C., et al. kDNA markers define two major Trypanosoma rangeli lineages in Latin-America. Acta Trop 2002, 81:77-82.
8. Grisard E.C., Campbell D.A., Romanha A.J. Mini-exon gene sequence polymorphism among Trypanosoma rangeli strains isolated from distinct geographical regions. Parasitology 1999, 118(Pt 4):375-382.
9. Gonzalez V.D., Garcia V.S., Vega J.R., Marcipar I.S., Meira G.R., Gugliotta L.M. Immunodiagnosis of Chagas disease: synthesis of three latex-protein complexes containing different antigens of Trypanosoma cruzi. Colloids Surf B Biointerfaces 2010, 77:12-17.
10. Flechas I.D., Cuellar A., Cucunuba Z.M., Rosas F., Velasco V., Steindel M., et al. Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients. BMC Infect Dis 2009, 9:186.
11. Afchain D., Le Ray D., Fruit J., Capron A. Antigenic make-up of Trypanosoma cruzi culture forms: identification of a specific component. J Parasitol 1979, 65:507-514.
12. Saldana A., Sousa O.E. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi. J Parasitol 1996, 82:363-366.
13. Parada C., Villalba J., Alvarez M., Puig N., Planelles D., Ramada C., et al. Trypanosoma rangeli in a blood donor at the Valencian Blood Transfusion Centre. Vox Sang 2010, 99:193-194.
14. de Moraes M.H., Guarneri A.A., Girardi F.P., Rodrigues J.B., Eger I., Tyler K.M., et al. Different serological cross-reactivity of Trypanosoma rangeli forms in Trypanosoma cruzi-infected patients sera. Parasites and Vectors 2008, 1:20.
15. Guhl F., Jaramillo C., Carranza J.C., Vallejo G.A. Molecular characterization and diagnosis of trypanosoma cruzi and T. rangeli. Arch Med Res 2002, 33:362-370.
16. Epting C.L., Coates B.M., Engman D.M. Molecular mechanisms of host cell invasion by Trypanosoma cruzi. Exp Parasitol 2010, 126:283-291.
17. Nakayasu E.S., Sobreira T.J., Torres R., Ganiko L., Oliveira P.S., Marques A.F., et al. Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi. J Proteome Res 2012, 11:237-246.
18. Almeida I.C., Gazzinelli R.T. Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses. J Leukoc Biol 2001, 70:467-477.
19. Overath P., Steverding D., Chaudhri M., Stierhof Y.D., Ziegelbauer K. Structure and function of GPI-anchored surface proteins of Trypanosoma brucei. Braz J Med Biol Res 1994, 27:343-347.
20. Nakayasu E.S., Yashunsky D.V., Nohara L.L., Torrecilhas A.C., Nikolaev A.V., Almeida I.C. GPIomics: global analysis of glycosylphosphatidylinositol-anchored molecules of Trypanosoma cruzi. Mol Syst Biol 2009, 5:261.
21. Frasch A.C. Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. Parasitol Today 2000, 16:282-286.
22. Rojas A., Garcia-Lugo P., Crisante G., Anez-Rojas N., Anez N. Isolation, purification, characterization and antigenic evaluation of GPI-anchored membrane proteins from Leishmania (Viannia) braziliensis. Acta Trop 2008, 105:139-144.
23. Ferguson M.A. The surface glycoconjugates of trypanosomatid parasites. Philos Trans R Soc Lond B Biol Sci 1997, 352:1295-1302.
24. Brittingham A., Morrison C.J., McMaster W.R., McGwire B.S., Chang K.P., Mosser D.M. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J Immunol 1995, 155:3102-3111.
25. Acosta-Serrano A., Almeida I.C., Freitas-Junior L.H., Yoshida N., Schenkman S. The mucin-like glycoprotein super-family of Trypanosoma cruzi: structure and biological roles. Mol Biochem Parasitol 2001, 114:143-150.
26. Bartholomeu D.C., Cerqueira G.C., Leao A.C., daRocha W.D., Pais F.S., Macedo C., et al. Genomic organization and expression profile of the mucin-associated surface protein (masp) family of the human pathogen Trypanosoma cruzi. Nucleic Acids Res 2009, 37:3407-3417.
27. Pollevick G.D., Di Noia J.M., Salto M.L., Lima C., Leguizamon M.S., de Lederkremer R.M., et al. Trypanosoma cruzi surface mucins with exposed variant epitopes. J Biol Chem 2000, 275:27671-27680.
28. Buscaglia C.A., Campo V.A., Frasch A.C., Di Noia J.M. Trypanosoma cruzi surface mucins: host-dependent coat diversity. Nat Rev Microbiol 2006, 4:229-236.
29. Dc-Rubin S.S., Schenkman S. Trypanosoma cruzi trans-sialidase as a multifunctional enzyme in Chagas' disease. Cell Microbiol 2012, 14:1522-1530.
30. Previato J.O., Jones C., Xavier M.T., Wait R., Travassos L.R., Parodi A.J., et al. Structural characterization of the major glycosylphosphatidylinositol membrane-anchored glycoprotein from epimastigote forms of Trypanosoma cruzi Y-strain. J Biol Chem 1995, 270:7241-7250.
31. Grisard E.C., Stoco P.H., Wagner G., Sincero T.C., Rotava G., Rodrigues J.B., et al. Transcriptomic analyses of the avirulent protozoan parasite Trypanosoma rangeli. Mol Biochem Parasitol 2010, 174:18-25.
32. Ferreira K.A., Ruiz J.C., Dias F.C., Lages-Silva E., Tosi L.R., Ramirez L.E., et al. Genome survey sequence analysis and identification of homologs of major surface protease (gp63) genes in Trypanosoma rangeli. Vector Borne Zoonotic Dis 2010, 10:847-853.
33. Abate T., Rincon M., Diaz-Bello Z., Spencer L., Rodriguez-Acosta A. A mucin like gene different from the previously reported members of the mucin like gene families is transcribed in Trypanosoma cruzi but not in Trypanosoma rangeli. Mem Inst Oswaldo Cruz 2005, 100:391-395.
34. Saldana A., Sousa O.E., Orn A., Harris R.A. Trypanosoma rangeli sialidase: kinetics of release and antigenic characterization. Acta Trop 1998, 70:87-99.
35. Pontes-de-Carvalho L.C., Tomlinson S., Nussenzweig V. Trypanosoma rangeli sialidase lacks trans-sialidase activity. Mol Biochem Parasitol 1993, 62:19-25.
36. Anezrojas N., Garcialugo P., Crisante G., Rojas A., Anez N. Isolation, purification and characterization of GPI-anchored membrane proteins from Trypanosoma rangeli and Trypanosoma cruzi. Acta Trop 2006, 97:140-145.
37. Pena C.P., Lander N., Rodriguez E., Crisante G., Anez N., Ramirez J.L., et al. Molecular analysis of surface glycoprotein multigene family TrGP expressed on the plasma membrane of Trypanosoma rangeli epimastigotes forms. Acta Trop 2009, 111:255-262.
38. Koerich L.B., Emmanuelle-Machado P., Santos K., Grisard E.C., Steindel M. Differentiation of Trypanosoma rangeli: high production of infective Trypomastigote forms in vitro. Parasitol Res 2002, 88:21-25.
39. Teixeira M.M., Yoshida N. Stage-specific surface antigens of metacyclic trypomastigotes of Trypanosoma cruzi identified by monoclonal antibodies. Mol Biochem Parasitol 1986, 18:271-282.
40. Cordero E.M., Nakayasu E.S., Gentil L.G., Yoshida N., Almeida I.C., da Silveira J.F. Proteomic analysis of detergent-solubilized membrane proteins from insect-developmental forms of Trypanosoma cruzi. J Proteome Res 2009, 8:3642-3652.
41. Horton P., Park K.J., Obayashi T., Fujita N., Harada H., Adams-Collier C.J., et al. WoLF PSORT: protein localization predictor. Nucleic Acids Res 2007, 35:W585-W587.
42. Emanuelsson O., Brunak S., von Heijne G., Nielsen H. Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc 2007, 2:953-971.
43. Poisson G., Chauve C., Chen X., Bergeron A. FragAnchor: a large-scale predictor of glycosylphosphatidylinositol anchors in eukaryote protein sequences by qualitative scoring. Genomics Proteomics Bioinformatics 2007, 5:121-130.
44. Bologna G., Yvon C., Duvaud S., Veuthey A.L. N-terminal myristoylation predictions by ensembles of neural networks. Proteomics 2004, 4:1626-1632.
45. Ren J., Wen L., Gao X., Jin C., Xue Y., Yao X. CSS-Palm 2.0: an updated software for palmitoylation sites prediction. Protein Eng Des Sel 2008, 21:639-644.
46. Hansen J.E., Lund O., Tolstrup N., Gooley A.A., Williams K.L., Brunak S. NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility. Glycoconj J 1998, 15:115-130.
47. Tusnady G.E., Simon I. The HMMTOP transmembrane topology prediction server. Bioinformatics 2001, 17:849-850.
48. Wistrand M., Sonnhammer E.L. Improved profile HMM performance by assessment of critical algorithmic features in SAM and HMMER. BMC Bioinformatics 2005, 6:99.
49. Barrell D., Dimmer E., Huntley R.P., Binns D., O'Donovan C., Apweiler R. The GOA database in 2009 - an integrated Gene Ontology Annotation resource. Nucleic Acids Res 2009, 37:D396-D403.
50. Sant'Anna C., Nakayasu E.S., Pereira M.G., Lourenco D., de Souza W., Almeida I.C., et al. Subcellular proteomics of Trypanosoma cruzi reservosomes. Proteomics 2009, 9:1782-1794.
51. Atwood J.A., Weatherly D.B., Minning T.A., Bundy B., Cavola C., Opperdoes F.R., et al. The Trypanosoma cruzi proteome. Science 2005, 309:473-476.
52. Ko Y.G., Thompson G.A. Purification of glycosylphosphatidylinositol-anchored proteins by modified triton X-114 partitioning and preparative gel electrophoresis. Anal Biochem 1995, 224:166-172.
53. Saldana A., Harris R.A., Orn A., Monroy C., Ortega-Barria E., Sousa O.E. Antigenic significance of a Trypanosoma rangeli sialidase. J Parasitol 2002, 88:697-701.
54. Freitas L.M., dos Santos S.L., Rodrigues-Luiz G.F., Mendes T.A., Rodrigues T.S., Gazzinelli R.T., et al. Genomic analyses, gene expression and antigenic profile of the trans-sialidase superfamily of Trypanosoma cruzi reveal an undetected level of complexity. PLoS One 2011, 6:e25914.
55. El-Sayed N.M., Myler P.J., Bartholomeu D.C., Nilsson D., Aggarwal G., Tran A.N., et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 2005, 309:409-415.
56. Cuevas I.C., Cazzulo J.J., Sanchez D.O. gp63 homologues in Trypanosoma cruzi: surface antigens with metalloprotease activity and a possible role in host cell infection. Infection and. Immunity 2003, 71:5739-5749.
57. Etges R., Bouvier J., Bordier C. The major surface protein of Leishmania promastigotes is anchored in the membrane by a myristic acid-labeled phospholipid. EMBO J 1986, 5:597-601.
58. Ma L., Chen K., Meng Q., Liu Q., Tang P., Hu S., et al. An evolutionary analysis of trypanosomatid GP63 proteases. Parasitol Res 2011, 109:1075-1084.
59. Serrano A.A., Schenkman S., Yoshida N., Mehlert A., Richardson J.M., Ferguson M.A. The lipid structure of the glycosylphosphatidylinositol-anchored mucin-like sialic acid acceptors of Trypanosoma cruzi changes during parasite differentiation from epimastigotes to infective metacyclic trypomastigote forms. J Biol Chem 1995, 270:27244-27253.
60. Almeida I.C., Ferguson M.A., Schenkman S., Travassos L.R. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem J 1994, 304(Pt 3):793-802.
61. Di Noia J.M., Pollevick G.D., Xavier M.T., Previato J.O., Mendoca-Previato L., Sanchez D.O., et al. High diversity in mucin genes and mucin molecules in Trypanosoma cruzi. J Biol Chem 1996, 271:32078-32083.
62. Di Noia J.M., D'Orso I., Aslund L., Sanchez D.O., Frasch A.C. The Trypanosoma cruzi mucin family is transcribed from hundreds of genes having hypervariable regions. J Biol Chem 1998, 273:10843-10850.
63. Urban I., Santurio L.B., Chidichimo A., Yu H., Chen X., Mucci J., et al. Molecular diversity of the Trypanosoma cruzi TcSMUG family of mucin genes and proteins. Biochem J 2011, 438:303-313.
64. Quanquin N.M., Galaviz C., Fouts D.L., Wrightsman R.A., Manning J.E. Immunization of mice with a TolA-like surface protein of Trypanosoma cruzi generates CD4(+) T-cell-dependent parasiticidal activity. Infect Immun 1999, 67:4603-4612.
65. Basso B., Moretti E., Fretes R. Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 2008, 103:370-374.
66. Cooper R., de Jesus A.R., Cross G.A. Deletion of an immunodominant Trypanosoma cruzi surface glycoprotein disrupts flagellum-cell adhesion. J Cell Biol 1993, 122:149-156.
67. Nozaki T., Haynes P.A., Cross G.A. Characterization of the Trypanosoma brucei homologue of a Trypanosoma cruzi flagellum-adhesion glycoprotein. Mol Biochem Parasitol 1996, 82:245-255.
68. LaCount D.J., Barrett B., Donelson J.E. Trypanosoma brucei FLA1 is required for flagellum attachment and cytokinesis. J Biol Chem 2002, 277:17580-17588.
69. Porcel B.M., Bontempi E.J., Henriksson J., Rydaker M., Aslund L., Segura E.L., et al. Trypanosoma rangeli and Trypanosoma cruzi: molecular characterization of genes encoding putative calcium-binding proteins, highly conserved in trypanosomatids. Exp Parasitol 1996, 84:387-399.
70. Godsel L.M., Engman D.M. Flagellar protein localization mediated by a calcium-myristoyl/palmitoyl switch mechanism. EMBO J 1999, 18:2057-2065.
71. Mansfield J.M. T-cell responses to the trypanosome variant surface glycoprotein: a new paradigm?. Parasitol Today 1994, 10:267-270.
72. Reinitz D.M., Mansfield J.M. T-cell-independent and T-cell-dependent B-cell responses to exposed variant surface glycoprotein epitopes in trypanosome-infected mice. Infect Immun 1990, 58:2337-2342.
73. Nakazawa M., Rosa D.S., Pereira V.R., Moura M.O., Furtado V.C., Souza W.V., et al. Excretory-secretory antigens of Trypanosoma cruzi are potentially useful for serodiagnosis of chronic Chagas' disease. Clin Diagn Lab Immunol 2001, 8:1024-1027.
74. Pereira V.R., Nakazawa M., Furtado V.C., Abath F.G., Gomes Y.M. Immunodiagnosis of chronic Chagas' disease using the Tc 46 and Tc 58 antigens. Rev Soc Bras Med Trop 2000, 33:367-370.